# Medical Chart Review of Patients on Long-term Treatment With Long-acting Injectable Risperidone

> **NCT00644852** · — · COMPLETED · sponsor: **Johnson & Johnson Taiwan Ltd** · enrollment: 342 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **OTHER:** Retrospective chart review study

## Key facts

- **NCT ID:** NCT00644852
- **Lead sponsor:** Johnson & Johnson Taiwan Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 342 (ACTUAL)
- **Last updated:** 2014-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00644852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00644852, "Medical Chart Review of Patients on Long-term Treatment With Long-acting Injectable Risperidone". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00644852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*